Ranibizumab for the treatment of retinopathy of prematurity: systematic review and meta-analysis

Anti-VEGF drugs like ranibizumab can be used to treat retinopathy of prematurity (ROP) by halting the formation of abnormal blood vessels, or lasers can be used to burn the edges of the retina where these vessels are present. The objective is to compare the efficacy for ROP between ranibizumab and l...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Frontiers in pediatrics 2023-08, Vol.11, p.1202927-1202927
Hauptverfasser:	Alva, Niza, Martínez, Alex R., Ortiz-Saavedra, Brando, Montes-Madariaga, Elizbet S., Cotrina, Alonso, Caballero-Alvarado, José A., Sah, Ranjit, Barboza, Joshuan J.
Format:	Artikel
Sprache:	eng
Schlagworte:	laser therapy meta-analysis Pediatrics ranibizumab retinopathy of prematurity systematic review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Anti-VEGF drugs like ranibizumab can be used to treat retinopathy of prematurity (ROP) by halting the formation of abnormal blood vessels, or lasers can be used to burn the edges of the retina where these vessels are present. The objective is to compare the efficacy for ROP between ranibizumab and laser therapy.
ISSN:	2296-2360 2296-2360
DOI:	10.3389/fped.2023.1202927